Klug entscheiden in der Geriatrie


  1. AGS Choosing Wisely Workgroup: American Geriatrics Society identifies five things that healthcare providers and patients should question. J Am Geriatr Soc 2013; 61: 622–31. 
  2. AGS Choosing Wisely Workgroup: American Geriatrics Society identifies another five things that healthcare providers and patients should question. J Am Geriatr Soc 2014; 62: 950–60. 
  3. Vance J: AMDA – Choosing Wisely. JAMDA 2013; 14: 639–641. 
  4. www.choosingwisely.org/. 
  5. www.choosingwiselycanada.org recommendations/geriatrics/. 
  6. Gogol M: Choosing Wisely – ein Modell für das deutsche Gesundheitswesen? Z Gerontol Geriatr 2014; 47: 23–6. 
  7. Ellis G, Whitehead MA, Robinson D, et al.: Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ 2011; 343: d6553. 
  8. Deschodt M, Flamaing J, Haentjens P, et al.: Impact of geriatric consultation teams on clinical outcome in acute hospitals: a systematic review and metaanalysis. BMC Med 2013; 11: 48 
  9. Puts MT, Santos B, Hardt J, et al.: An update on a systematic review of the use of geriatric assessment for older adults in oncology. Ann Oncol 2014; 25: 307–15. 
  10. Palumbo A, Bringhen S, Mateos MV, et al.: Geriatric assessment predicts survival and toxicities in elderly myeloma patients: and international Myeloma Working Group report. Blood 2015; 125: 2068–74. 
  11. Van Craen K, Braes T, Wellens N, et al.: The effectiveness of inpatient geriatric evaluation and management units: a systematic review and meta-analysis. J Am Geriatr Soc 2010; 58: 83–92. 
  12. Partridge JS, Harari D, Martin FC, Dhesi JK: The impact of pre-operative comprehensive geriatric assessment on postoperative outcomes in older patients undergoing scheduled surgery: a systematic review. Anaesthesia 2014; 69 (Suppl 1): 8–16. 
  13. Visnjevac O, Lee J, Pourafkari L, et al.: Functional capacity as a significant independent predictor of postoperative mortality of octogenarian ASA-III patients. J Gerontol A Biol Sci Med Sci 2014; 69: 1229–35. 
  14. Joseph B, Pandit V, Zangbar B, et al.: Superiority of frailty over age in predicting outcomes among geriatric trauma patients. JAMA Surg 2014; 149: 83–9. 
  15. Monk TG, Weldon BC, Garvan CW, et al.: Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 2008; 108: 18–30. 
  16. Gillespie LD, Robertson MC, Gillespie WJ, et al.: Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2012; 9: CD007146. 
  17. Health Quality Ontario: Prevention of falls and fall-related injuries in communitydwelling seniors: an evidence-based analysis. Ont Health Technol Assess Ser 2008; 8: 1–78. 
  18. Cameron ID, Gillespie LD, Robertson MC, et al.: Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev 2012; 12: CD005465. 
  19. Deandreas S, Bravi F, Turati F, et al.: Risk factors for falls in older people in nursing homes and hospitals. A systematic review and meta-analysis. Arch Gerontol Geriatr 2013; 56: 407–15. 
  20. Stubs B, Denkinger M, Brefka S, Dallmeier D: What works to prevent falls in older adults dwelling in long term care facilities and hospitals? An umbrella review of meta-analysis of randomised controlled trials. Maturitas 2015; 81: 335–42. 
  21. Hagen KB, Dagfinrud H, Moe RH, et al.: Exercise therapy for bone and muscle health: an overview of systematic reviews. BMC Med. 2012; 10: 167. 
  22. Sherrington C, Tiedemann A, Fairhall N, et al.: Exercise to prevent falls in older adults: an updated meta-analysis and best practice recommendations. N S W Public Health Bull 2011; 22: 78–83. 
  23. Liu CJ, Latham NK: Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst Rev 2009; (3): CD002759. 
  24. Borde R, Hortobágyi T, Granacher U: Dose-response relationships of resistance training in healthy old adults: a systematic review and meta-analysis. Sports Med 2015: 45: 1693–720. 
  25. Lesinski M, Hortobágyi T, Muehlbauer T, et al.: Effects of balance training on balance performance in healthy older adults: a systematic review and metaanalysis. Sports Med 2015; 45: 1721–38. 
  26. Bachmann S, Finger C, Huss A, et al.: Inpatient rehabilitation specifically designed for geriatric patients: systematic review and meta-analysis of randomised controlled trials. BMJ 2010; 340: c1718. 
  27. Avenell A, Mak JC, O’Connell D: Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 2014; 4: CD000227. 
  28. Murad MH, Elamin KB, Abu Elnour NO, et al.: Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011; 96: 2997–3006. 
  29. Stockton KA, Mengersen K, Paratz JD, et al.: Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int 2011; 22: 859–71. 
  30. 3Annweiler C, Beauchet O: Questioning vitamin D status of elderly fallers and nonfallers: a meta-analysis to address a „forgotten step“. J Intern Med. 2015; 277: 16–44. 
  31. Halfon M, Phan O, Teta D: Vitamin D: a review on ist effects on muscle strength, the risk of fall, and frailty. Biomed Res Int 2015; 2015: 953241. 
  32. Milne AC, Potter J, Vivanti A, Avenell A: Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev 2009; (2): CD003288. 
  33. Cawood AL, Elia M, Stratton RJ: Systematic review and meta-analysis of the effects of high protein oral nutritional supplements. Ageing Res Rev 2012; 11: 278–96. 
  34. Volkert D, Bauer JM, Frühwald T, et al.: Klinische Ernährung in der Geriatrie. Leitlinie der Deutschen Gesellschaft für Ernährungsmedizin (DGEM) in Zusammenarbeit mit der GESKES, der AKE und der DGG. Aktuel Ernährungsmed 2013; 38: e1–e48. 
  35. Volkert D, Berner YN, Berry E, et al.: ESPEN guidelines on enteral nutrition: geriatrics. Clin Nutr 2006; 25: 330–60. 
  36. 36. Marshall S, Bauer J, Isenring E: The consequences of malnutrition following discharge from rehabilitation to the community: a systematic review of current evidence in older adults. J Hum Nutr Diet 2014; 27: 133–41. 
  37. Kimber K, Gibbs M, Weekes CE, Baldwin C: Supportive interventions for enhancing dietary intake in malnourished or nutritionally at-risk adults: a systematic review of nonrandomised studies. J Hum Nutr Diet. 2015; 28: 517–45. 
  38. Stratton RJ, Hébuterne X, Elia M: A systematic review and meta-analysis of the impact of oral nutritional supplements on hospital readmissions. Ageing Res Rev 2013; 12: 884–897.
  39. DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (Hrsg.) für die Leitliniengruppe Unipolare Depression: S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung, 1. Auflage. Version 5.2009, zuletzt verändert: Juni 2015. www.depression.versorgungsleit linien.de; [17.10.2015]; doi: 10.6101/ AZQ/000239. 
  40. Melchior H, Schulz H, Härter M: Faktencheck Gesundheit. Regionale Unterschiede in der Diagnostik und Behandlung von Depressionen. 2014. 
  41. Cooper C, Katona C, Lyketsos K, et al.: A systematic review of treatments for refractory depression in older adults. Am J Psychiatry 2011; 168: 681–8. 
  42. Coupland C, Dhiman P, Moriss R, et al.: Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 2011; 343: d4551. 
  43. Locher C, Kossowsky J, Gaab J, et al.:Moderation of antidepressant and placebo outcomes by baseline severity in latelife depression: a systematic review and meta-analysis. J Affect Disord 2015; 181: 50–60
  44. Kirkham JG, Choi N, Seitz D: Meta-analysis of problem solving therapy for the treatment of major depressive disorder in older adults. Int J Geriatr Psychiatry 2016; 31: 526–35. 
  45. Wilson KC, Mottram PG, Vassilas CA: Psychotherapeutic treatments for older depressed people. Cochrane Database Syst Rev 2008; (1): CD004853. 
  46. Huang AX, Delucchi K, Dunn LB, Nelson JC: A systematic review and meta-analysis of psychotherapy for late-life depression. Am J Geriatr Psychiatry 2015; 23: 261–73. 
  47. Wilkinson P, Izmeth Z: Continuation and maintenance treatments for depression in older people. Cochrane Database Syst Rev 2012; 11: CD006727.
  48. Dachverband Osteologie: Prophylaxe, Diagnostik und Therapie der Osteoporose bei Männern ab dem 60. Lebensjahr und bei postmenopausalen Frauen. S3-Leitlinie des Dachverbands der Deutschsprachigen Wissenschaftlichen Osteologischen Gesellschaften e.V. 2014. www.dv-osteologie.org dvo_leitlinien/osteoporose-leitlinie- 2014. 
  49. Pfeilschifter J: Osteoporose-Diagnostik. Was ist neu in der DVO-Leitlinie 2014) Dtsch Med Wochenschr 2015; 140: 1667–71. 
  50. Rush L, McCartney G, Walsh D, MacKay D: Vitamin D and subsequent all-age and premature mortality: a systematic review. BMC Public Health 2013; 13: 679. 
  51. Schöttker B, Ball D, Gellert C, Brenner H: Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev 2013; 12: 708–18. 
  52. Hadjii P, Claus V, Ziller V, et al.: GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates. Osteoporos Int 2012; 23: 223–31. 
  53. Ziller V, Kostev K, Kyvernitakis I, et al.: Persistence and compliance of medica - tions used in the treatment of osteoporosis – analysis using a large scale, representative, longitudinal German database. Int J Clin Pharmacol Ther 2012; 50: 315–22. 
  54. National Committee for Quality Assurance: Improving quality and patient experience – the state of health care quality 2013. Washington (DC): National Committee for Quality Assurance; Oktober 2013, S. 206. 
  55. Shrank WH, Polinski JM, Avorn J: Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc 2007; 55 (Suppl. 2): S373–82. 
  56. Hajjar ER, Cafiero AC, Hanlon JT: Polypharmacy in elderly patients. Am J Geriatr Pharm 2007; 5: 345–51. 
  57. Steinman MA, Hanlon JT: Managing medications in clinically complex elders: “There’s got to be a happy medium”. JAMA 2010; 304: 1592–601. 
  58. Drenth-van Maanen AC, van Marum RJ, Knol W, et al.: Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy. Drugs Aging 2009; 26: 687–701. 
  59. Patterson SM, Cadogan CA, Kerse N, et al.: Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2014; 10: CD008165. 
  60. Santos AP, da Silva DT, Dos Santos Júnior GA, et al.: Evaluation of the heterogeneity of studies estimating the association between risk factors and the use of potentially inappropriate drug therapy for the elderly: a systematic review with meta-analysis. Eur J Clin Pharmacol 2015; 71: 1037–50. 
  61. 61. Boeker EB, Ram K, Klopotowska JE, de et al.: An individual patient data metaanalysis on factors associated with adverse drug events in surgical and nonsurgical inpatients. Br J Clin Pharmacol 2015; 79: 548–57. 
  62. Hanlon JT, Semla TP, Schmader KE: Alternative medications for medications in the use of high-risk medications in the elderly and potentially harmful drug-disease interactions in the elderly quality measures. J Am Geriatr Soc 2015; 63: e8–18. 
  63. Kuhn-Thiel AM, Weiß C, Wehling M: FORTA authors/expert panel members: Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly. Drugs Aging 2014; 31: 131–40. 
  64. Wehling M, Burkhardt H, Kuhn-Thiel A, et al.: VALFORTA: a randomized trial to validate the FORTA (Fit fOR The Aged) classification. Age Ageing 2016; 45: 262–67. 
  65. O’Mahony D, O’Sullivan D, Byrne S, et al.: STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2015; 44: 213–18. 
  66. Renom-Guiteras A, Meyer G, Thürmann PA: The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol 2015; 71: 861–75. 
  67. American Geriatrics Society 2015 Beers Criteria Update Expert Panel: American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2015; 63: 2227–46. 
  68. Finucane TE, Christmas C, Travis K: Tube feeding in patients with advanced dementia: a review of the evidence. JAMA 1999; 282: 1365–70. 
  69. Gabriel SE, Normand ST: Getting the methods right – the foundation of patientcentered outcomes research. N Engl J Med 2012; 367: 787–90. 23. 
  70. Teno JM, Feng Z, Mitchell SL, et al.: Do financial incentives of introducing case mix reimbursement increase feeding tube use in nursing home residents? J Am Geriatr Soc 2008; 56: 887–90. 
  71. Teno JM, Mitchell SL, Kuo SK, et al.: Decision- making and outcomes of feeding tube insertion: a five-state study. J Am Geriatr Soc 2011; 59: 881–86. 
  72. Palecek EJ, Teno JM, Casarett DJ, et al.: Comfort feeding only: a proposal to bring clarity to decision-making regarding difficulty with eating for persons with advanced dementia. J Am Geriatr Soc 2010; 58: 580–84. 
  73. Hanson LC, Carey TS, Caprio AJ, et al.: Improving decision-making for feeding options in advanced dementia: a randomized, controlled trial. J Am Geriatr Soc 2011; 59: 2009–16. 
  74. Teno JM, Gozalo PL, Mitchell SL, et al.: Does feeding tube insertion and its timing improve survival? J Am Geriatr Soc 2012; 60: 1918–21. 
  75. Hanson LC, Ersek M, Gilliam R, Carey TS: Oral feeding options for people with dementia: a systematic review. J Am Geriatr Soc 2011; 59: 463–72. 
  76. Palecek EJ, Teno JM, Casarett DJ, et al.: Comfort feeding only: a proposal to bring clarity to decision-making regarding difficulty with eating for persons with advanced dementia. J Am Geriatr Soc 2010; 58: 580–84. 
  77. Sorrell JM: Use of feeding tubes in patients with advanced dementia: are we doing harm? J Psychosoc Nurs Ment Health Serv 2010; 48: 15–8. 
  78. Sampson EL, Candy B, Jones L: Enteral tube feeding for older people with advanced dementia. Cochrane Database Syst Rev 2009; (2): CD007209. 
  79. Gillick MR, Volandes AE: The standard of caring: why do we still use feeding tubes in patients with advanced dementia? J Am Med Dir Assoc 2008; 9: 364–67. 
  80. 80. Ganzini L: Artificial nutrition and hydration at the end of life: ethics and evidence. Palliat Support Care 2006; 4: 135–43. 
  81. Li I: Feeding tubes in patients with severe dementia. Am Fam Physician 2002; 65: 1605–11. 
  82. Mitchell SL, Kiely DK, Lipsitz LA: The risk factors and impact on survival of feeding tube placement in nursing home residents with severe cognitive impairment. Arch Intern Med 1997; 157: 327–32. 
  83. National Institute for Health and Clinical Excellence and Social Care Institute for Excellence NICE-SCIE: National Collaborating Centre for Mental Health. Clinical guidelines 42: Dementia: Supporting people with dementia and their carers in health and social care. London 2006: Amended 2011. www.nice.org.uk/CG042.
  84. Maher A, Maglione M, Bagley S, et al.: Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA 2011; 306: 1359–69. 
  85. Schneider LS, Tariot PN, Dagerman KS, et al.: Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. N Engl J Med 2006; 355: 1525–38. 
  86. Gitlin LN, Kales HC, Lyketsos, CG: Nonpharmacologic management of behavioral symptoms in dementia. JAMA 2012; 308: 2020–29. 
  87. American Medical Directors Association: Dementia in the long term care setting clinical practice guideline. Columbia, MD: AMDA 2012. www.amda. com/education/moodandbehavior/AM DA%20CPG_Dementia.pdf 
  88. Flaherty J, Gonzales J, Dong B: Antipsychotics in the treatment of delirium in older hospitalized adults: a systematic review. J Am Geriatr Soc 2011; 59 (Suppl 2): S269–76. 
  89. Ozbolt LB, Paniagua MA, Kaiser RM: Atypical antipsychotics for the treatment of delirious elders. J Am Med Dir Assoc 2008; 9: 18–28. 
  90. Schneeweiss S, Setoguchi S, Brookhart A, et al.: Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 2007; 176: 627–32. 
  91. Gill SS, Bronskill SE, Normand SL, et al.: Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007; 146: 775–86. 
  92. Schneider LS, Dagerman K, Insel PS: Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006; 14: 191–210. 
  93. Sink KM, Holden KF, Yaffe K: Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005; 293: 596–608. 
  94. Schneider LS, Dagerman KS, Insel P: Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294: 1934–43. 
  95. Kales HC, Gitlin LN, Lyketsos CG, Detroit Expert Panel on the Assessment and Management of the Neuropsychiatric Symptoms of Dementia: Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel. J Am Geriatr Soc 2014; 62: 762–69. 
  96. Schröder FH, Hugosson J, Roobol MJ, et al.: Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012; 366: 981–90. 
  97. Moyer VA, U.S. Preventive Services Task Force: Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157: 120–34. 
  98. Walter LC, Covinsky KE: Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285: 2750–56. 
  99. Lee SJ, Boscardin WJ, Stijacic-Cenzer I, et al.: Time lag to benefit after screening for breast and colorectal cancer: metaanalysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ 2012; 346: e8441. 
  100. van Hees F, Habbema JD, Meester RG, et al.: Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med 2014; 160: 750–9. 
  101. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al.: Reduced lung-cancer mortality with lowdose computed tomographic screening. N Engl J Med 2011; 365: 395–409. 
  102. Woolf SH, Harris RP, Campos-Outcalt D: Low-dose lung computed tomography screening for lung cancer: how strong is the evidence? JAMA Intern Med 2014; 174: 2019–22. 
  103. Clarfield AM: Screening in frail older people: an ounce of prevention or a pound of trouble? J Am Geriatr Soc 2010; 58: 2016–21. 
  104. Gill TM: The central role of prognosis in clinical decision making. JAMA 2012; 307: 199–200. 
  105. Gross CP: Cancer screening in older persons: a new age of wonder. JAMA Intern Med 2014; 174: 1565–67. 
  106. Lee SJ, Leipzig RM, Walter LC: Incorporating lag time to benefit into prevention decision for older adults. JAMA 2013; 310: 2609–10. 
  107. Lonsdorp-Vogelaar I, Gulati R, Mariotto AB, et al.: Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Ann Intern Med 2014; 161: 104–12. 
  108. Royce TJ, Hendrix LH, Stokes WA, et al.: Cancer screening rates in individuals with different life expectancies. JAMA Intern Med 2014; 174: 1558–65. 
  109. Finkle WD, Der JS, Greenland S, et al.: Risk of fractures requiring hospitalization after an initial prescription of zolpidem, alprazolam, lorazepam or diazepam in older adults. J Am Geriatr Soc 2011; 59: 1883–90. 
  110. Allain H, Bentue-Ferrer D, Polard E, et al.: Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs Aging 2005; 22: 749–65. 
  111. Kripke DF, Langer RD, Kline LE. Hypnotics’ association with mortality or cancer: a matched cohort study. BMJ Open 2012; 2: e000850. 
  112. Glass J, Lanctôt KL, Herrmann N, et al.: Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005; 331: 1169. 
  113. Sivertsen B, Omvik S, Pallesen S, et al.: Cognitive behavioral therapy vs zopi - clone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA 2006; 295: 2851–58.

Wir verwenden Cookies auf Ihrem Browser, um die Funktionalität unserer Webseite zu optimieren und den Besuchern personalisierte Werbung anbieten zu können. Bitte bestätigen Sie die Auswahl der Cookies um direkt zu der Webseite zu gelangen. Weitere Informationen finden Sie unter Datenschutz. Dort können Sie auch jederzeit Ihre Cookie-Einstellungen ändern.

Mehr Info